載入...
INNV-28. TEMOZOLOMIDE IN RENAL DYSFUNCTION
BACKGROUND: Temozolomide (TMZ) is a cytotoxic DNA alkylating agent. It is the only chemotherapy known to improve survival in patients with high grade astrocytomas. The active alkylating species, methylhydrazine, is not recovered in the urine and thus renal function is not expected to affect clearanc...
Na minha lista:
| 發表在: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7651152/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.511 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|